Belantamab mafodotin User Reviews & Ratings
Brand names: Blenrep
Belantamab mafodotin has an average rating of 1.0 out of 10 from a total of 1 reviews on drugclasses.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Multiple Myeloma | 1 reviews for Multiple Myeloma | 68 medications | |
Add your review |
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about belantamab mafodotin
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Blenrep (belantamab mafodotin) for Multiple Myeloma "Not great, after 6 weeks started to have dry eyes and blurry vision. Had to change glasses prescription twice in 1 month despite stopping."